Impact of changes in neurotrophic supplementation on development of Alzheimer’s disease-like pathology in OXYS rats

[1]  H. Braak,et al.  Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases. , 2016, Cold Spring Harbor perspectives in biology.

[2]  E. Rogaev,et al.  Changes in the transcriptome of the prefrontal cortex of OXYS rats as signs of the development of Alzheimer’s disease , 2016, Russian Journal of Genetics: Applied Research.

[3]  N. Stefanova,et al.  Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer's disease‐like pathology , 2015, Journal of pineal research.

[4]  L. Yanshole,et al.  Beneficial effects of melatonin in a rat model of sporadic Alzheimer’s disease , 2015, Biogerontology.

[5]  O. Sinitsyna,et al.  Influence of antioxidant SkQ1 on accumulation of mitochondrial DNA deletions in the hippocampus of senescence-accelerated OXYS rats , 2015, Biochemistry (Moscow).

[6]  N. Stefanova,et al.  Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats , 2014, Oncotarget.

[7]  O. Kozhevnikova,et al.  Senescence-accelerated OXYS rats: A model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease , 2014, Cell cycle.

[8]  V. Skulachev,et al.  Alzheimer's disease-like pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondria-targeted antioxidant SkQ1. , 2013, Journal of Alzheimer's disease : JAD.

[9]  Y. Barde,et al.  Death of developing neurons: New insights and implications for connectivity , 2013, The Journal of cell biology.

[10]  Mu-ming Poo,et al.  Neurotrophin regulation of neural circuit development and function , 2012, Nature Reviews Neuroscience.

[11]  J. Morley,et al.  The senescence accelerated mouse (SAMP8) as a model for oxidative stress and Alzheimer's disease. , 2012, Biochimica et biophysica acta.

[12]  Naruhiko Sahara,et al.  Propagation of Tau Pathology in a Model of Early Alzheimer's Disease , 2012, Neuron.

[13]  N. Kolosova,et al.  Age-Specific Peculiarities of Formation of Long-Term Posttetanic Potentiation in OXYS Rats , 2011, Bulletin of experimental biology and medicine.

[14]  I. Koptyug,et al.  Effect of malate on the development of rotenone-induced brain changes in Wistar and OXYS rats: An MRI study , 2011, Doklady Biological Sciences.

[15]  Woong Sun,et al.  Programmed cell death during postnatal development of the rodent nervous system , 2011, Development, growth & differentiation.

[16]  Sayuri Yamazaki,et al.  The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation , 2010, PloS one.

[17]  C. Pilon,et al.  Cyclotraxin-B, the First Highly Potent and Selective TrkB Inhibitor, Has Anxiolytic Properties in Mice , 2010, PloS one.

[18]  M. Constantine‐Paton,et al.  Postsynaptic BDNF‐TrkB signaling in synapse maturation, plasticity, and disease , 2010, Developmental neurobiology.

[19]  S. Paul,et al.  Brain-Derived Neurotrophic Factor Reduces Amyloidogenic Processing through Control of SORLA Gene Expression , 2009, The Journal of Neuroscience.

[20]  H. Jacobsen,et al.  Alzheimer's disease: from pathology to therapeutic approaches. , 2009, Angewandte Chemie.

[21]  B. Fox,et al.  β-Amyloid1–42 Induces Neuronal Death through the p75 Neurotrophin Receptor , 2008, The Journal of Neuroscience.

[22]  N. Kolosova,et al.  Development of behavioural dysfunctions in accelerated-senescence OXYS rats is associated with early postnatal alterations in brain phosphate metabolism , 2006, Experimental Gerontology.

[23]  G. Perini,et al.  Role of p75 Neurotrophin Receptor in the Neurotoxicity by β-amyloid Peptides and Synergistic Effect of Inflammatory Cytokines , 2002, The Journal of experimental medicine.

[24]  N. Stefanova,et al.  [MORPHOLOGICAL CHARACTERIZATION OF OXYS AND WISTAR RAT HIPPOCAMPUS IN THE AGING PROCESS]. , 2015, Morfologiia.

[25]  N. Unsain,et al.  Neurotrophins in the regulation of cellular survival and death. , 2014, Handbook of experimental pharmacology.

[26]  M. Bothwell.  NGF, BDNF, NT3, and NT4. , 2014, Handbook of experimental pharmacology.